ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2010

Aug 30, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2010-08-27

Reporting Person: Myszkowski Kenneth Allen (CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-08-27	Common Stock	P	15000	$0.89	Acquired	15000	Direct